Price Alert

Cross Country Healthcare ... (CCRN)

NASDAQ: CCRN · Real-Time Price · USD

13.37

0.36 (2.77%)

At close: Aug 15, 2025, 3:59 PM

13.61

1.80%

After-hours: Aug 15, 2025, 05:46 PM EDT

Cross Country Healthcare Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	918.47M	1.26B	1.34B	1.45B	1.58B	1.78B	2.02B	2.23B	2.43B	2.64B	2.81B	2.82B	2.56B	2.14B	1.68B	1.25B	1.07B	955.59M
Cost of Revenue	733.66M	1.01B	1.08B	1.16B	1.25B	1.4B	1.57B	1.74B	1.88B	2.05B	2.18B	2.18B	1.98B	1.66B	1.3B	969.34M	824.19M	731M
Gross Profit	180.47M	246.55M	260.55M	288.92M	322.12M	379.17M	445.94M	498.86M	545.05M	592.32M	627.69M	635.89M	576.14M	478.33M	375M	282.24M	246.45M	224.59M
Operating Income	-7.42M	-14.59M	-5.5M	11.36M	28.81M	77.03M	112.71M	150.75M	182.63M	226.27M	273.11M	297.61M	271.88M	208.94M	139.3M	69M	42.18M	12.59M
Interest Income	1.62M	2.32M	1.64M	1.11M	5K	5K	5K	5K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-7.15M	-20.99M	-16.4M	485K	16.6M	66.46M	102.89M	136.28M	165.48M	209.32M	256.32M	283.27M	259.21M	199.97M	133.21M	64.58M	38.96M	9.62M
Net Income	-8.35M	-17.74M	-14.56M	-1.76M	8.49M	45.89M	72.63M	102.38M	124.36M	155.91M	188.46M	227.24M	215.88M	174.54M	132M	59.04M	34.27M	8.57M
Selling & General & Admin	212.4M	241.47M	253.53M	265.52M	280.85M	280.67M	300.39M	317.14M	327.73M	334.8M	327.35M	308.81M	281.44M	245.78M	215.29M	194.39M	182.34M	174.25M
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	194.88M	27.08M	19.93M	266.05M	256.06M	594.46M	599.37M	343.39M	346.74M	9.2M	7.02M	7.17M	4.33M	3.45M	770K	290K	-75K	-274K
Operating Expenses	407.29M	268.33M	273.24M	531.36M	541.37M	879.81M	904.43M	665.22M	674.48M	346.42M	336.79M	320.95M	293.04M	256.1M	225.14M	203.72M	192.24M	185.88M
Interest Expense	2.25M	2.27M	2.19M	2.17M	2.29M	4.87M	8.09M	11.02M	13.85M	14.56M	14.39M	13.69M	12.38M	9.72M	6.87M	4.72M	3.15M	2.69M
Selling & Marketing Expenses	n/a	n/a	n/a	11.5M	11.5M	11.5M	11.5M	16.1M	16.1M	16.1M	16.1M	9.5M	9.5M	9.5M	9.5M	-1.01M	-1.01M	-1.01M
Cost & Expenses	920.02M	1.27B	1.35B	1.36B	1.47B	1.53B	1.73B	1.99B	2.14B	2.4B	2.52B	2.5B	2.27B	1.91B	1.53B	1.17B	1.02B	916.88M
Income Tax Expense	1.19M	-3.25M	-1.84M	2.25M	8.1M	20.58M	30.26M	33.89M	41.11M	53.41M	67.86M	56.03M	43.33M	25.43M	1.21M	5.32M	4.29M	546K
Shares Outstanding (Basic)	32.49M	32.28M	32.34M	33.02M	33.96M	34.22M	34.48M	34.95M	35.35M	35.86M	36.45M	37.1M	37.47M	37.03M	36.97M	36.96M	36.63M	36.18M
Shares Outstanding (Diluted)	32.49M	32.28M	32.34M	33.06M	33.96M	34.6M	34.69M	35.15M	35.52M	36.56M	36.93M	37.49M	37.76M	37.97M	37.74M	37.58M	37.2M	37.03M
EPS (Basic)	-0.26	-0.53	-0.43	-0.05	0.24	1.31	2.05	2.85	3.42	4.23	5.08	6.12	5.81	4.72	3.59	1.62	0.95	0.24
EPS (Diluted)	-0.26	-0.53	-0.43	-0.05	0.23	1.30	2.03	2.82	3.39	4.19	5.01	6.03	5.72	4.63	3.53	1.59	0.93	0.23
EBITDA	12.81M	-387K	3.99M	20.98M	37.25M	89.42M	129.34M	164.34M	195.04M	238.65M	283.29M	309.1M	283.19M	220M	149.93M	80.29M	53.47M	25.31M
EBIT	277K	-18.72M	-14.21M	2.65M	18.88M	71.33M	110.99M	147.3M	179.33M	223.88M	270.72M	296.97M	271.59M	209.68M	140.07M	69.3M	42.1M	12.31M
Depreciation & Amortization	17.71M	18.33M	18.2M	18.33M	18.37M	18.37M	18.88M	17.57M	16.68M	15.88M	14.01M	14.13M	13.74M	12.69M	12.28M	11.2M	11.18M	12.25M